Aspergillus Antigen EIA

309

The Aspergillus Antigen EIA test aids in the diagnosis of systemic aspergillosis in animals. This test has low sensitivity in dogs with sino-nasal aspergillosis; therefore, the test is not recommended for screening in those cases.

Platelia™ Aspergillus EIA immunoenzymatic sandwich microplate assay, cleared by the FDA for the detection of galactomannan in serum or BALF.

The result is not intended to be used as the sole means for clinical diagnosis or patient management decisions.

• Antifungal therapy may cause false negative results in patients with aspergillosis.
• Low positive results (0.5-1.5 GMI) are equivocal and may represent false positives, as the cutoff of 0.5 GMI was determined based on human studies for the early diagnosis of invasive fungal infections.

• Certain gluconate containing fluids (Vetivex pHLyte NOT Plasmalyte or Norm-R)
• Potentially penicillin antibiotics
• High: Alternaria, Fusarium, Geotrichum, Paecilomyces
• Low: Coccidioides, Cryptococcus, Blastomyces, Histoplasma

Test Setup:  Monday – Friday
Urine/Serum/CSF/BAL: Results Released in 24 – 48 hours

*New positives may require confirmation

Negative

Negative: <0.5

*Results are reported as numeric values (Index) which are interpreted as positive or negative.

Platelia™ is a registered trademark of BioRad.

Specimen: Urine, Serum, CSF, BAL

Container:
Serum: Collect serum specimens in serum separator tube. Allow blood to clot for 30 minutes, then centrifuge. Send serum in serum separator tube or transfer tube.
Urine/CSF/BAL: Submit Urine, CSF, and BAL in a sterile leak proof plastic tube.

Volume: 0.8mL
Stability: Room temperature = 48 hours; Refrigerated = 5 days; Frozen = 5 months

If specimen is too viscous to pipette.

Refrigerated/Frozen

Ship overnight or 2^nd day-ambient or with cold pack.